Terms: = Germ cell tumor AND WRN, RECQL2, 7486, ENSG00000165392, Q14191, RECQ3 AND Prognosis
5 results:
1. Construction of a SUMOylation regulator-based prognostic model in low-grade glioma.
Li X; Meng Y
J Cell Mol Med; 2021 Jun; 25(12):5434-5442. PubMed ID: 33951297
[TBL] [Abstract] [Full Text] [Related]
2. Whole-genome sequencing of recurrent neuroblastoma reveals somatic mutations that affect key players in cancer progression and telomere maintenance.
Fransson S; Martinez-Monleon A; Johansson M; Sjöberg RM; Björklund C; Ljungman G; Ek T; Kogner P; Martinsson T
Sci Rep; 2020 Dec; 10(1):22432. PubMed ID: 33384420
[TBL] [Abstract] [Full Text] [Related]
3. Multimodal brain tumor image segmentation using wrn-PPNet.
Wang Y; Li C; Zhu T; Zhang J
Comput Med Imaging Graph; 2019 Jul; 75():56-65. PubMed ID: 31154088
[TBL] [Abstract] [Full Text] [Related]
4. wrn Cys1367Arg SNP is not associated with risk and prognosis of gliomas in Southeast Brazil.
Pinto GR; Yoshioka FK; Clara CA; Santos MJ; Almeida JR; Burbano RR; Rey JA; Casartelli C
J Neurooncol; 2008 Dec; 90(3):253-8. PubMed ID: 18670736
[TBL] [Abstract] [Full Text] [Related]
5. Regulators of G-protein signaling 3 and 4 (RGS3, RGS4) are associated with glioma cell motility.
Tatenhorst L; Senner V; Püttmann S; Paulus W
J Neuropathol Exp Neurol; 2004 Mar; 63(3):210-22. PubMed ID: 15055445
[TBL] [Abstract] [Full Text] [Related]
